Up-Regulated Expression of Thioredoxin-Interacting Protein (TXNIP) in Mesenchymal Stem Cells Associated with Severe

Ying-Hsuan Peng1,2, Chang-Wei Li3, Kang-Hsi Wu1,4

  • 1Department of Pediatrics, Chung Shan Medical University Hospital, Taichung 402, Taiwan.

Insights

Bone marrow mesenchymal stem cells (MSCs) in children with severe aplastic anemia (SAA) show increased senescence and altered gene expression. TXNIP up-regulation and IGFBP-1 increase may contribute to SAA pathogenesis.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Molecular Medicine

Background:

  • Severe aplastic anemia (SAA) pathogenesis in children is not fully understood.
  • Bone marrow microenvironment insufficiency, involving mesenchymal stem cells (MSCs), is a potential factor in SAA-related hematopoietic impairment.

Purpose of the Study:

  • To investigate the characteristics of bone marrow MSCs in children with SAA.
  • To identify molecular mechanisms contributing to SAA pathogenesis.

Main Methods:

  • Comparison of bone marrow MSCs from five children with SAA and five healthy controls.
  • Assessment of senescence-associated β-galactosidase activity.
  • RNA sequencing analysis to identify differential gene expression.
  • Quantitative PCR (qPCR) validation.
  • Measurement of IGF-1 and IGFBP-1 expression levels.

Main Results:

  • SAA MSCs exhibited higher senescence-associated β-galactosidase activity.
  • RNA sequencing revealed distinct transcriptomes in SAA MSCs, with up-regulated TXNIP.
  • qPCR validated TXNIP up-regulation.
  • SAA MSCs showed significantly increased IGFBP-1 expression, despite variable IGF-1 levels.

Conclusions:

  • Increased TXNIP expression in SAA MSCs may impair their proliferative potential and contribute to SAA pathogenesis.
  • A potential pathogenic mechanism involves a compensated increase in MSC IGF-1 to down-regulate TXNIP, which is counteracted by elevated IGFBP-1 expression in SAA.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K